Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating Expenses:
General and administrative	$ 470,768	$ 480,875	$ 1,626,352	$ 2,097,801
Total Operating Expenses	831,625	995,380	3,163,433	3,316,394
Loss From Operations	(831,625)	(995,380)	(3,163,433)	(3,316,394)
Other (Expense) Income:
Gain on extinguishment of note payable	17,893		17,893	41,920
Total Other Expense	(585,516)	(342,758)	(1,017,902)	(954,915)
Net Loss	(1,417,141)	(1,338,138)	(4,181,335)	(4,271,309)
Dividend attributable to Series A, B, and C preferred stockholders	(350,984)	(309,150)	(1,017,520)	(907,516)
Net Loss Applicable to Common Stockholders	$ (1,768,125)	$ (1,647,288)	$ (5,198,855)	$ (5,178,825)
Net Loss Per Common Share - Basic	$ (0.04)	$ (0.04)	$ (0.13)	$ (0.14)
Net Loss Per Common Share - Diluted	$ (0.04)	$ (0.04)	$ (0.13)	$ (0.14)
Weighted Average Common Shares Outstanding - Basic	42,426,449	38,191,731	41,321,759	37,492,478
Weighted Average Common Shares Outstanding - Diluted	42,426,449	38,191,731	41,321,759	37,492,478
Nonrelated Party [Member]
Operating Expenses:
Research and development	$ 346,357	$ 500,005	$ 1,493,581	$ 1,175,093
Other (Expense) Income:
Interest expense	(95,865)	(62,463)	(136,213)	(138,937)
Interest expense - amortization of debt discount	(74,718)	(29,912)	(112,218)	(107,487)
Change in fair value of derivative liabilities	(62,851)		(50,034)
Related Party [Member]
Operating Expenses:
Research and development	14,500	14,500	43,500	43,500
Other (Expense) Income:
Interest expense	(260,921)	(199,628)	(594,326)	(496,206)
Interest expense - amortization of debt discount	(73,355)	(50,755)	(111,434)	(254,205)
Change in fair value of derivative liabilities	$ (35,699)		$ (31,570)